




Looking forward to keynote talks from @HansClevers, @TheMeltonLab & @GVNlab @CellSymposia #CSStemCells22 #stemcells #LosAngeles #California @CedarsSinaiMed December 8–10, 2022 Register here hubs.li/Q01rNvCk0

G. Oliver @NU_Lymphatics (🇺🇸@NUFeinbergMed), C. Blanpain @CedricBlanpain (🇧🇪@ULBruxelles) & D. Melton @TheMeltonLab (🇺🇸@harvardstemcell) are the guest speakers in the #ISDB2021 session “𝗙𝗿𝗼𝗺 𝗱𝗲𝘃𝗲𝗹𝗼𝗽𝗺𝗲𝗻𝘁 𝘁𝗼 𝗱𝗶𝘀𝗲𝗮𝘀𝗲” Join us in 🇵🇹👉 ISDB2021.com/registration

Using a CRISPR screen and single cell analyses we asked how do stem cell-derived islets (SC-islets) react to immunological pressure (allogeneic). Among the hits we identified CXCL10 depletion as a way to escape immune rejection of grafted #betacells. cell.com/stem-cell-reports/f…

Take a look at the speaker line-up for #CSStemCells22, including keynotes @HansClevers, @TheMeltonLab & @GVNlab #stemcells #LosAngeles #California @CedarsSinaiMed hubs.li/Q01d-_NX0

Couldn’t ask for a better closure for my postdoc era. Was so great to attend and present at #ISSCR2022! Met so many old and new friends/colleagues. Some of which you see only in meetings like these every few years. Hope to see you all next year in Boston #ISSCR2023 @ISSCR

Cell maturation: Hallmarks, triggers, and manipulation @TheMeltonLab @Harvard @JuanAlvarezDom @PennCDB @IRM_Upenn @CellCellPress #ISSCR2022 hubs.li/Q01dFNRR0

Tomorrow 6/16 at #ISSCR2022, excited to present 'Immunogenicity of stem-cell derived islets as defined be a whole-genome CRISPR screen'. In person or virtual. 1:45pm PDT/4:45pm EDT, at 'Stem Cell Bioengineering - enhancing cell function'.

Happy to share a pre-print of some work from my time in the @TheMeltonLab. First and foremost, many thanks to all the co-authors involved!! Now, for a brief outline of the findings..
Secreted cytokines provide local immune tolerance for human stem cell-derived islets biorxiv.org/cgi/content/shor… #bioRxiv

Check out our latest pre-print entitled “Whole Genome CRISPR Screening of Stem Cell Derived Islets Reveals Gene Targets for Hypo-Immunogenicity”
Glad and excited to share our online pre-print of a paper submitted for peer review in @CellStemCell. We report a whole genome CRISPR screen and transcriptomic profiling of immune challenged stem cell derived islet cells. See thread below ssrn.com/abstract=4081520

I’ve finally settled back home in Sydney, Australia with my family. I’d like to thank Doug and all my colleagues in the @TheMeltonLab for the wonderful years together. Hope to see you soon Down Under!

This is just one of many good things that might happen when you listen to the Stem Cell Report. Hear more from Doug Melton @TheMeltonLab & @naleite at https://t.co/8T5SyJZd3o & read their recent paper, https://t.co/xxOt5N7Oh2. @harvardstemcell @VertexPharma @ISSCR @martinperaJAX

⏰ Don't miss the opportunity to hear groundbreaking research & to network with this impressive line-up of past #ISSCR presidents at the #ISSCR2022 Annual Meeting 15-18 June in San Francisco. Register by 11:59 EDT 13 April for the best rates 👉 ow.ly/oLJM50IJcqW

Probably the last time together with these outstanding people and outstanding mentor. Thank you @TheMeltonLab

It was a pleasure to participate with @TheMeltonLab on the @stemcellreports podcast. Thank you for having me!
👏 Our new podcast is out! Learn about the latest research & potential clinical approaches using #stemcell-based treatments for type 1 #diabetes. 🎧 ow.ly/Xe6m50IxJlU Read 👉 https://t.co/Inxp7UDaG7 @martinperaJAX @TheMeltonLab @harvardstemcell @naleite @VertexPharma

👨🔬Hear abt Doug Melton's latest work developing #stemcell therapies for #diabetes @ our Jerusalem symposium. His pioneering work deriving insulin-producing beta islets cells from PSCs led to the 1st in-human clinical trial ow.ly/7FAe50Im00X @HSCRB @harvardstemcell @Harvard